Jeremy Grimshaw

Dr. Jeremy M. Grimshaw, MBChB, PhD, FRCGP, FCAHS is a Canadian health information specialist and epidemiologist based in Ottawa, Ontario.

Grimshaw is a Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake.1)

Education

Career and Affiliations

Canadian Academy of Health Sciences

Grimshaw is a fellow of the Canadian Academy of Health Sciences.2)

University of Ottawa

Grimshaw is a professor in the Department of Medicine at the University of Ottawa.3)

Campbell Collaboration

Grimshaw is the President of the Board of the Directors of the Campbell Collaboration.4)

He was initially elected as co-chair in 2016.5)

The Ottawa Hospital

Grimshaw is a Senior Scientist in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute.6)

Eastern Ontario Regional Laboratory Association

Grimshaw sits on the board of directors at the Eastern Ontario Regional Laboratory Association.7)

AcademyHealth

Grimshaw has been a presenter for AcademyHealth.8)

Ontario COVID-19 Science Advisory Table

Grimshaw is a member of the Behavioural Science Working Group of the Ontario COVID-19 Science Advisory Table.9)

Research

Grimshaw received a strategic grant from the Cardiac Arrhythmia Network of Canada for a study titled “Decreasing Hospital Admissions from the Emergency Department for Acute Atrial Fibrillation”.10) CANC is partnered with many organizations with interest in COVID-19 including Apotex, Bayer, Boehringer Ingelheim, IBM, Johnson & Johnson, LifeLabs, Medtronic, Pfizer, and St. Jude Medical (an Abbott company).11)

COVID-19

Grimshaw is a co-Principal Investigator and co-Chair of the COVID-END study, funded by the Canadian Institutes of Health Research (CIHR).12) He is also a member of the Canadian secretariat.13)

Grimshaw is a co-founder of the Behavioural, Environmental, Social and System Interventions Collaboration (BESSI), “which aims to promote research into BESSIs to reduce transmission and mitigate the effects of the pandemic.”14)

Grimshaw is a co-investigator for the Coronavirus Variants Rapid Response Network (CoVaRR-Net), funded by the Canadian Institutes of Health Research (CIHR).15)

Vaccine hesitancy

Grimshaw received funding from the Public Health Agency of Canada (PHAC) for a study on vaccine hesitancy related to COVID-19 vaccines.16)

Diabetes

Grimshaw received an operating grant from as a co-Principal Investigator from Diabetes Action Canada for a study called “An implementation science approach to increase attendance to retinopathy screening by people with diabetes.”17) DAC is funded by AstraZeneca, Bayer, Merck and Sun Life Financial.18)

Antimicrobial Resistance

Grimshaw has published research on antimicrobial resistance with funding by the Joint Programming Initiative on Antimicrobial Resistance Network (JPIARN).19)

Awards and Recognition

Grimshaw was recognized as a Thomson Reuters Highly Cited Researcher in 2015, 2016 2017 and 2018.20) 21)

1)
Jeremy M. Grimshaw. (2021, June 25). Government of Canada. https://archive.ph/nAcbI
2)
Jeremy Grimshaw. McMaster University Health Forum. Retrieved May 8, 2022, from https://archive.ph/om3b0
3)
Grimshaw, Jeremy. Department of Epidemiology. Retrieved May 8, 2022, from https://archive.ph/eFdqy
4)
Campbell Board. Campbell Collaboration. Retrieved May 8, 2022, from https://archive.ph/FHcwL
5)
Campbell Collaboration elects Jeremy Grimshaw as new co-Chair. (2016, April 5). Campbell Collaboration. https://archive.ph/pjlp1
6)
Jeremy Grimshaw. Ottawa Hospital Research Institute. Retrieved May 8, 2022, from http://www.ohri.ca/profile/jgrimshaw
7)
Board of Directors. Eastern Ontario Regional Laboratory Association. Retrieved May 8, 2022, from https://archive.ph/dHgGJ
8)
Jeremy Grimshaw, MB.Ch.B., Ph.D. AcademyHealth. Retrieved May 8, 2022, from https://web.archive.org/web/20220508091404/https://academyhealth.org/about/people/jeremy-grimshaw-mbchb-phd
9)
About Us. Ontario COVID-19 Science Advisory Table. Retrieved April 28, 2022, from https://covid19-sciencetable.ca/about/
11)
About Us. (2021, September 28). Cardiac Arrhythmia Network of Canada (CANet). https://canet-nce.ca/about/
14)
About | Behavioural, Environmental, Social and Systems Interventions. BESSI-Collab. Retrieved May 8, 2022, from https://www.bessi-collab.net/about-us
15)
Our Team. CoVaRR-Net. Retrieved May 8, 2022, from https://archive.ph/EWWMo
16)
Crawshaw, J., Konnyu, K., Castillo, G., Zack Van Allen, Mba, M., Grimshaw, J., & Presseau, J. (2021). Factors affecting COVID-19 vaccination acceptance and uptake among the general public: a living behavioural science evidence synthesis. McMaster University Health Forum. https://web.archive.org/web/20220509061411/https://www.mcmasterforum.org/docs/default-source/product-documents/living-evidence-syntheses/covid-19-living-evidence-synthesis-4.1---factors-affecting-covid-19-vaccination-acceptance-and-uptake-among-the-general-public.pdf?sfvrsn=5368712f_7
18)
Strategic Partners. Diabetes Action Canada - SPOR Network. Retrieved May 8, 2022, from https://archive.ph/upCkV
19)
Rzewuska, M., Charani, E., Clarkson, J. E., Davey, P. G., Duncan, E. M., Francis, J. J., Gillies, K., Kern, W. V., Lorencatto, F., Marwick, C. A., McEwen, J., Möhler, R., Morris, A. M., Ramsay, C. R., Rogers Van Katwyk, S., Skodvin, B., Smith, I., Suh, K. N., & Grimshaw, J. M. (2019). Prioritizing research areas for antibiotic stewardship programmes in hospitals: a behavioural perspective consensus paper. Clinical Microbiology and Infection, 25(2), 163–168. https://doi.org/10.1016/j.cmi.2018.08.020
20)
ICES scientists Peter Austin and Jeremy Grimshaw selected as 2016 Thomson Reuters Highly Cited Researchers. (2016, November 18). ICES. https://archive.ph/ieRPL
Print/export